Summit Trail Advisors LLC Grows Stake in Aflac Incorporated (NYSE:AFL)

Summit Trail Advisors LLC boosted its position in shares of Aflac Incorporated (NYSE:AFL) by 57.1% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,367 shares of the financial services provider’s stock after purchasing an additional 4,494 shares during the quarter. Summit Trail Advisors LLC’s holdings in Aflac were worth $1,383,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Lazard Asset Management LLC increased its holdings in shares of Aflac by 19.4% in the 1st quarter. Lazard Asset Management LLC now owns 1,520 shares of the financial services provider’s stock valued at $130,000 after acquiring an additional 247 shares during the period. Price T Rowe Associates Inc. MD boosted its position in shares of Aflac by 1.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 882,906 shares of the financial services provider’s stock worth $75,808,000 after purchasing an additional 12,357 shares in the last quarter. Bayesian Capital Management LP acquired a new stake in shares of Aflac in the 1st quarter worth $270,000. Motley Fool Asset Management LLC boosted its position in shares of Aflac by 5.9% in the 1st quarter. Motley Fool Asset Management LLC now owns 17,048 shares of the financial services provider’s stock worth $1,464,000 after purchasing an additional 956 shares in the last quarter. Finally, Creekmur Asset Management LLC boosted its position in shares of Aflac by 10,946.2% in the 1st quarter. Creekmur Asset Management LLC now owns 5,744 shares of the financial services provider’s stock worth $493,000 after purchasing an additional 5,692 shares in the last quarter. 67.44% of the stock is currently owned by hedge funds and other institutional investors.

Aflac Price Performance

Shares of Aflac stock opened at $112.39 on Monday. Aflac Incorporated has a twelve month low of $75.07 and a twelve month high of $115.50. The business has a 50-day moving average price of $110.73 and a 200 day moving average price of $100.66. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32. The firm has a market cap of $62.44 billion, a PE ratio of 16.93, a P/E/G ratio of 2.15 and a beta of 0.96.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, topping the consensus estimate of $1.69 by $0.47. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The company had revenue of $2.95 billion during the quarter, compared to analyst estimates of $4.30 billion. During the same period in the previous year, the business earned $1.84 EPS. Aflac’s quarterly revenue was down 40.4% on a year-over-year basis. Sell-side analysts predict that Aflac Incorporated will post 7.22 earnings per share for the current fiscal year.

Aflac Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.78%. The ex-dividend date of this dividend is Wednesday, November 20th. Aflac’s dividend payout ratio (DPR) is 30.12%.

Wall Street Analyst Weigh In

A number of analysts have commented on AFL shares. Truist Financial lifted their price target on Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. Evercore ISI boosted their price objective on Aflac from $84.00 to $90.00 and gave the company an “underperform” rating in a report on Thursday, September 26th. Barclays started coverage on Aflac in a report on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 price objective for the company. TD Cowen started coverage on Aflac in a report on Wednesday, October 9th. They issued a “hold” rating and a $102.00 price objective for the company. Finally, Morgan Stanley boosted their price objective on Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a report on Monday, August 19th. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Aflac has an average rating of “Hold” and a consensus price target of $97.93.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.